Firm record
Alfresa Holdings
◇Private·—·GICS Biotech, health care & pharma
Partial profile
We haven't fully researched Alfresa Holdings yet.
Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.
We’ll only use your email to notify you about this request.
Targets & commitments2
| Source | Type | Scope | Base | Target year | Value | Status |
|---|---|---|---|---|---|---|
| nzt | net_zero | Scope 1 + 2 | — | 2051 | — | In corporate strategy |
| nzt | near_term | Scope 1 + 2 | 2021 | 2025 | 10% | In corporate strategy |
Identifiers
| isin | JP3126340003 |
| nzt_id | COM-1633 |
| Reverberate ID | c0c553f3… |